SEI INVESTMENTS CO - AMPHASTAR PHARMACEUTICALS IN ownership

AMPHASTAR PHARMACEUTICALS IN's ticker is AMPH and the CUSIP is 03209R103. A total of 250 filers reported holding AMPHASTAR PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.

Quarter-by-quarter ownership
SEI INVESTMENTS CO ownership history of AMPHASTAR PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$1,221,311
+243.5%
26,556
+329.3%
0.00%
+100.0%
Q2 2023$355,506
-34.3%
6,186
-57.1%
0.00%0.0%
Q1 2023$540,840
-24.9%
14,422
-43.7%
0.00%
-50.0%
Q3 2022$720,000
-66.0%
25,632
-57.7%
0.00%
-60.0%
Q2 2022$2,115,000
+46.3%
60,625
+51.2%
0.01%
+66.7%
Q1 2022$1,446,000
+30.4%
40,107
-27.3%
0.00%0.0%
Q4 2020$1,109,000
-34.0%
55,158
-38.5%
0.00%
-40.0%
Q3 2020$1,681,000
+6.8%
89,658
+27.9%
0.01%0.0%
Q2 2020$1,574,000
+43.2%
70,094
-5.3%
0.01%
+25.0%
Q1 2020$1,099,000
-30.4%
74,049
-9.5%
0.00%
-20.0%
Q4 2019$1,578,000
-5.8%
81,823
-3.1%
0.01%
+25.0%
Q3 2019$1,675,000
-6.1%
84,4830.0%0.00%
-33.3%
Q2 2019$1,783,000
+40.1%
84,483
+35.6%
0.01%
+50.0%
Q1 2019$1,273,000
-35.4%
62,295
-38.5%
0.00%
-42.9%
Q4 2018$1,972,000
+50.9%
101,341
+49.2%
0.01%
+40.0%
Q3 2018$1,307,000
+26.0%
67,9340.0%0.01%
+25.0%
Q2 2018$1,037,000
-14.5%
67,934
+4.9%
0.00%
-20.0%
Q1 2018$1,213,000
-6.1%
64,741
-3.6%
0.01%
+25.0%
Q4 2017$1,292,000
+0.1%
67,175
-7.0%
0.00%
-20.0%
Q3 2017$1,291,000
+0.1%
72,2510.0%0.01%0.0%
Q2 2017$1,290,000
-13.7%
72,251
-29.9%
0.01%
-28.6%
Q1 2017$1,495,000
+14850.0%
103,074
+20071.0%
0.01%
Q4 2016$10,000
+25.0%
511
+27.8%
0.00%
Q3 2016$8,0004000.00%
Other shareholders
AMPHASTAR PHARMACEUTICALS IN shareholders Q3 2023
NameSharesValueWeighting ↓
Alambic Investment Management, L.P. 29,423$583,0000.44%
Matarin Capital Management, LLC 223,184$4,426,0000.34%
Summit Global Investments 42,725$847,0000.10%
FEDERATED HERMES, INC. 1,747,921$34,661,0000.08%
ROTHSCHILD & CO ASSET MANAGEMENT US INC. 347,307$6,887,0000.08%
MARSHALL WACE, LLP 413,293$8,196,0000.06%
BOSTON ADVISORS LLC 42,365$840,0000.04%
MARTINGALE ASSET MANAGEMENT L P 214,444$4,254,0000.04%
JACOBS LEVY EQUITY MANAGEMENT, INC 177,321$3,516,0000.04%
SILVERCREST ASSET MANAGEMENT GROUP LLC 231,041$4,582,0000.04%
View complete list of AMPHASTAR PHARMACEUTICALS IN shareholders